eSMART

Cancer incidence and prevalence are growing, resulting in a rise in cancer and socio-economic burden that falls heavily on cancer patients and their families, and healthcare systems. Digital apps can help address this rising burden and be instrumental in the delivery of patient-focused, anticipatory care that improves treatment outcomes and the quality of life of cancer patients.

eSMART is conducting a clinical trial to evaluate the impact of a mobile phone-based symptom management intervention which records patient-reported outcomes and the delivery of care during chemotherapy and 1 year after treatment. eSMART demonstrates the effects of a real-time remote patient monitoring and care system that will help reduce symptoms experienced during chemotherapy and improve quality of life and survivorship. The project results will facilitate changes in clinical practice and lead to improved delivery of cancer care across Europe.

ECPC participated within the eSMART Project Technical Management Board, the Publications Committee and the Exploitation Committee, offering advice and feedback to ensure that the trial is designed and conducted in line with patient needs and preferences. ECPC also contributed to the communication and dissemination of the project, from communication planning and website development to various outreach activities to disseminate project results, including organising the final eSMART conference.